Therapeutic challenges in the management of osmotic demyelination syndrome: A case report of a favorable outcome from a tertiary center

Medicine (Baltimore). 2020 Jun 12;99(24):e20283. doi: 10.1097/MD.0000000000020283.

Abstract

Rationale: There is an increasing and compelling need for early recognition of features of osmotic demyelination syndrome (ODS), and a further attempt at correcting this even where presentation is late.

Patient concerns: A 49-year-old male admitted into the emergency department with a complaint of lethargy and severe hyponatremia, with subsequent ODS supervening on initial attempts at correction.

Diagnosis: Rapid rise in serum sodium concentration (121 mmol/L in 8 hours from a nadir of 101 mmol/L), concomitant deterioration in patient's conscious level support the diagnosis of ODS.

Intervention: Concomitant administration of 5% dextrose water with desmopressin with a therapeutic objective of gradual relowering of serum sodium concentration.

Outcomes: Significant improvement in patients' conscious level and motor function with the commencement of sodium relowering therapy. The patient was eventually discharged home.

Lessons: Regardless of the temporal profile of neurologic sequelae following ODS due to hyponatremia, its worthwhile attempting initial sodium relowering with dextrose 5% and desmopressin and then monitoring of biochemical and neurologic markers.

Publication types

  • Case Reports

MeSH terms

  • Antidiuretic Agents / administration & dosage
  • Antidiuretic Agents / therapeutic use
  • Brain / diagnostic imaging
  • Brain / pathology
  • Deamino Arginine Vasopressin / administration & dosage
  • Deamino Arginine Vasopressin / therapeutic use
  • Demyelinating Diseases / blood
  • Demyelinating Diseases / chemically induced*
  • Demyelinating Diseases / diagnosis
  • Demyelinating Diseases / therapy*
  • Drug Therapy, Combination / methods
  • Glucose / administration & dosage
  • Glucose / therapeutic use
  • Humans
  • Hyponatremia / complications*
  • Hyponatremia / therapy
  • Iatrogenic Disease
  • Lethargy / etiology
  • Magnetic Resonance Imaging / methods
  • Male
  • Middle Aged
  • Osmolar Concentration
  • Saline Solution, Hypertonic / adverse effects
  • Sodium / blood
  • Sweetening Agents / administration & dosage
  • Sweetening Agents / therapeutic use
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Antidiuretic Agents
  • Saline Solution, Hypertonic
  • Sweetening Agents
  • Sodium
  • Deamino Arginine Vasopressin
  • Glucose